|
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 0.6430 EUR | +5.93% |
|
+10.86% | -52.86% |
| 13.07. | AB Science stellt drei klinische Studien zu Masitinib ein | MT |
| 10.07. | AB Science strafft sein Portfolio und konzentriert sich auf zwei Wirkstoffe |  |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.26% | -1.56% | -0.95% | +13.42% | +21.92% | +58.84% | +22.22% | +69.77% | +100.96% | 316 Mrd. | |
| -0.92% | -0.07% | -0.45% | +31.16% | +18.27% | +34.38% | -10.27% | -23.02% | +46.61% | 73.28 Mrd. | |
| +0.43% | +0.37% | +5.21% | +26.90% | +24.21% | +37.46% | +97.10% | +106.80% | +696.85% | 9.87 Mrd. | |
| +1.81% | -5.70% | -8.65% | +4.41% | -1.11% | -4.47% | -6.11% | -27.77% | +51.09% | 8.15 Mrd. | |
| +2.76% | +8.47% | -4.87% | -17.42% | -34.19% | -26.39% | -14.85% | -35.69% | - | 4.38 Mrd. | |
| +0.40% | +6.83% | +6.68% | -17.02% | -33.19% | -34.64% | +7.29% | +40.00% | +82.80% | 3.91 Mrd. | |
| +2.46% | +2.71% | -18.26% | +14.73% | +27.63% | -17.02% | +21.19% | -33.80% | - | 3.62 Mrd. | |
| +8.46% | +0.73% | -2.37% | -4.64% | -5.61% | +24.99% | +45.77% | +76.42% | +102.99% | 2.51 Mrd. | |
| -0.19% | -0.38% | +1.66% | -11.79% | -12.84% | -2.51% | -3.33% | +73.30% | - | 2.24 Mrd. | |
| +1.75% | -0.22% | -4.84% | -12.68% | -6.40% | -25.96% | +29.50% | -32.34% | - | 1.76 Mrd. | |
| -0.91% | -0.11% | -2.58% | -9.38% | -13.96% | -23.50% | -16.52% | -9.85% | -42.07% | 1.74 Mrd. | |
| -.--% | -.--% | - | - | - | - | - | - | - | 1.64 Mrd. | |
| +0.31% | -4.49% | +22.59% | +51.32% | +171.85% | +212.08% | +1’602.59% | +680.48% | - | 1.26 Mrd. | |
| -0.03% | +6.82% | -11.52% | -28.98% | -16.36% | -48.34% | -18.88% | - | - | 1.19 Mrd. | |
| +4.60% | +9.00% | -5.01% | -37.61% | -36.85% | +52.14% | +41.72% | +23.52% | +477.66% | 1.17 Mrd. | |
| +1.41% | -5.94% | -3.88% | -9.17% | -14.84% | -12.00% | +12.82% | +72.17% | +57.39% | 1.02 Mrd. | |
| +4.21% | -0.90% | -32.17% | -10.13% | +4.21% | -6.28% | +73.68% | -5.81% | - | 1 Mrd. | |
| -0.79% | +3.58% | +1.48% | -17.12% | -20.15% | -37.01% | -73.60% | -81.27% | - | 930 Mio. | |
| -2.89% | +15.27% | -3.17% | -34.63% | -25.66% | +8.39% | +4.19% | -1.18% | +175.41% | 928 Mio. | |
| Durchschnitt | +1.22% | +2.55% | -3.39% | -3.81% | +2.61% | +10.56% | +100.81% | +52.46% | +174.97% | 22.99 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | +0.20% | -1.04% | -1.05% | +15.12% | +19.17% | +49.04% | +21.63% | +51.23% | +104.88% |
- Börse
- Aktien
- A1CXBG Aktie
- A1CXBG Aktie
- Sektor AB Science
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
